Elanco Animal Health Long-Term Investments 2016-2024 | ELAN
Elanco Animal Health long-term investments from 2016 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Elanco Animal Health long-term investments for the quarter ending June 30, 2024 were $M, a NAN% increase year-over-year.
- Elanco Animal Health long-term investments for 2023 were $0B, a NAN% decline from 2022.
- Elanco Animal Health long-term investments for 2022 were $0B, a NAN% decline from 2021.
- Elanco Animal Health long-term investments for 2021 were $0B, a NAN% decline from 2020.
| Elanco Animal Health Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $12 |
| 2016 | $9 |
| 2015 | $ |
| Elanco Animal Health Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | $15 |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2016-12-31 | $9 |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $7.242B | $4.417B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.379B | 12.93 |
| Quest Diagnostics (DGX) | United States | $17.308B | 17.75 |
| DaVita (DVA) | United States | $13.689B | 16.84 |
| Encompass Health (EHC) | United States | $9.303B | 22.88 |
| Chemed (CHE) | United States | $8.694B | 26.73 |
| Option Care Health (OPCH) | United States | $5.321B | 26.14 |
| RadNet (RDNT) | United States | $4.963B | 117.74 |
| Amedisys (AMED) | United States | $3.181B | 22.75 |
| Astrana Health (ASTH) | United States | $2.805B | 39.69 |
| LifeStance Health (LFST) | United States | $2.579B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.399B | 29.12 |
| U.S Physical Therapy (USPH) | United States | $1.274B | 34.50 |
| Pennant (PNTG) | United States | $1.057B | 50.71 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.022B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.208B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.025B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |